Fate Therapeutics Inc (NASDAQ:FATE) shares, rose in value on Wednesday, April 16, with the stock price down by -6.25% to the previous day’s close as strong demand from buyers drove the stock to $1.05. Actively observing the price movement in the last trading, the stock
The trading price of Fate Therapeutics Inc (NASDAQ:FATE) closed lower on Monday, April 14, and closing at $0.92, -12.80% lower than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $0.8651 and $1.13. In examining the
Fate Therapeutics Inc (NASDAQ:FATE) price closed lower on Tuesday, April 08, and dropping -0.40% below its previous close. A look at the daily price movement shows that the last close reads $0.91, with intraday deals fluctuated between $0.88 and $0.99. The company’s 5Y monthly beta
Fate Therapeutics Inc (NASDAQ:FATE) concluded the trading at $0.68 on Thursday, April 03 with a fall of -11.69% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $0.77 and 5Y monthly beta
Fate Therapeutics Inc (NASDAQ:FATE) traded at $0.80 at last check on current trade day and made a downward move of -5.79% on its previous day’s price. Looking at the stock we see that its previous close was $0.85 and the beta (5Y monthly) reads 2.264
The trading price of Fate Therapeutics Inc (NASDAQ:FATE) closed lower on Tuesday, March 25, and closing at $0.90, -4.05% lower than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $0.8915 and $0.9493. In examining the
Fate Therapeutics Inc (NASDAQ:FATE) price closed lower on current market day and dropping -0.21% below its previous close. A look at the daily price movement shows that the last close reads $0.94, with intraday deals fluctuated between $0.9102 and $0.9695. The company’s 5Y monthly beta
Fate Therapeutics Inc (NASDAQ:FATE) traded at $0.96 at close of the session on Tuesday, March 11 and made an upward move of 3.57% on its previous day’s price. Fate Therapeutics Inc has a market cap of $110.00 million and is expected to release its quarterly
Fate Therapeutics Inc (NASDAQ:FATE) shares, rose in value, with the stock price down by -0.48% to the previous day’s close as strong demand from buyers drove the stock to $1.03. Actively observing the price movement in the recent trading, the stock is buoying the session
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
